idarucizumab
UkraineDrugs containing this active substance
-
The drug is intended for adults taking dabigatran in cases where its action needs to be urgently stopped. This is necessary in life-threatening situations or uncontrolled bleeding, as well as for performing emergency surgeries or procedures.
Form: solution for injection/infusion
Active substance Dosage idarucizumab 50 mg/ml ATC: V03AB37
Manufacturer: Boehringer Ingelheim Pharma GmbH & Co. KG (manufacturing, primary and secondary packaging, quality control and batch release)